Company Profile

Replimune Group Inc

Name: Global Corporate Sustainability Reports Database
Creator: SustainabilityReports.com
License: https://creativecommons.org/licenses/by/4.0/

Replimune Group, Inc. is a clinical-stage biotechnology company focused on developing and commercializing next-generation oncolytic immunotherapies to treat cancer.

MIC

Ticker

LEI

FIGI

Website

replimune.com

Country

United States

Exchange

Nasdaq

Sector

Manufacturing

Industry

Pharmaceuticals

Reports

Available reports

2 total

Limited sustainability disclosure available

This company only publishes Annual Reports without dedicated sustainability sections.

Years

•